Last reviewed · How we verify
NCT05540639
Development and Evaluation of Somali-adapted Mindfetalness
NA trial testing Modified Mindfetalness in Prevention in 5,628 participants. Completed in 30 June 2024.
30 June 2024
Quick facts
| Lead sponsor | Sophiahemmet University |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | single group |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 5,628 |
| Start date | 11 January 2022 |
| Primary completion | 30 June 2024 |
| Estimated completion | 30 June 2024 |
| Sites | 1 location across Sweden |
Drugs / interventions tested
- Modified Mindfetalness
Conditions studied
- Prevention — all drugs for Prevention →
Sponsor
Sophiahemmet University
Who can join
Eligibility, female only, with Prevention. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Development of Somali-adapted Mindfetalness: Interviews with women born in Somalia A before-after study: Intervention: pregnant women receive a pamphlet, introduction to Mindfetalness by her midwife during the gestational-week 25 visit. The pregnant woman will well get access to a website concerning Mindfetalness. The pregnant women will be encouraged to start practicing Somali-adapted Mindfetalness during gestational week 28. Comparison: Intervention period (1/1-2022 to 31/12 2023) compared to 5 years before (1/1 2015 to 31/12 2019)
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
The effect of fetal movement awareness on birth outcomes among Somali migrant women - findings from a non-randomised intervention study in Sweden.
Andrén A, Rådestad I, Lindgren H, Erlandsson K, et al · · 2026 · PMID 41606544 · DOI 10.1186/s12884-026-08707-z
Verify or expand the search:
- PubMed search for NCT05540639
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Prevention
Currently open trials in the same condition.
- NCT07511491 — Ondansetron Lozenge Versus Intravenous for Prevention of Shivering in Cesarean Section · NA · recruiting
- NCT07248280 — Adding Aprepitant to a Multimodal Strategy for the Prevention of Postoperative Nausea and Vomiting in High-risk Outpatie · Phase 3 · recruiting
- NCT07382583 — Development of a Shared Decision Tool to Facilitate Uptake of the Levonorgestrel-releasing Intrauterine System for the P · recruiting
- NCT07498530 — Virtual Assistant for Exercise Adherence in Older ADULTS · NA · recruiting
- NCT06682494 — Enhancing Oral Cancer Awareness · NA · recruiting
Other Sophiahemmet University trials
Trials by the same sponsor.
- NCT05973383 — Evaluation of a Personalised Digital Intervention (EviBody) for Healthy and Sustained Lifestyle Behaviors and Well-being · not yet recruiting
- NCT06034184 — Enhancing Mass Casualty Triage Through Virtual Reality Simulation · NA · unknown
- NCT05806593 — Feasibility of a Person-centred Digital Program Targeting Physical Activity in Spinal Stenosis Surgery · NA · completed
- NCT04465435 — Sustainable UNiversity Life (SUN) Study · active not recruiting
- NCT02865759 — Mindfetalness to Improve Pregnancy Outcome · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05540639 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 20 May 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sophiahemmet University
- Last refreshed: 17 February 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05540639.